There's a great piece in the Wall Street Journal about how Wall Street's masters of the universe invest their own personal money through family offices, and how that can sometimes raise eyebrows across the industry. It's not hard to see why family offices can be a problem. Show More Summary
No one puts Acky in the corner.
This might be Pershing Square's finest work yet.
In fairness he did get a sweet apartment out of it.
That gross smell is Bill Ackman's salvation
Not even Icahn is enjoying this...well -yeah- he totally is...but it's still troubling.
Many of the traders I talk to are wondering what Bill Ackman could be thinking. Ackman is a hedge fund manager, the founder and CEO of Pershing Square Capital Management, which has about $11
His firm, Pershing Square Capital, took $4 billion in losses on an investment in pharma company.
Pershing Square Capital Management‘s Bill Ackman is sorry about his investment in Valeant Pharmaceuticals International (VRX). In his annual letter to shareholders in Pershing Square Holdings (PSH) Ackman wrote, “Clearly our investment was a huge mistake.” No kidding. The firm sold 27.2 million shares of the stock for around $11 a share, losing some $4 billion […]
In his annual letter to investors, Mr. Ackman apologized for the disastrous bet on Valeant Pharmaceuticals that resulted in a $4 billion loss for his hedge fund.
It's pricey, but nothing works like life experience.
Hedge fund billionaire Bill Ackman is not known around Wall Street for his humility. But after riding Valeant Pharmaceutical's stock down from a peak of $279 in 2015, to around $11 this month, he has something to say to his investors. "Clearly,...Show More Summary
While Bill Ackman has had some big winners for investors in his multi-billion-dollar hedge fund, Pershing Square, he also has cost his clients a ton of money over the years due to his high-risk bets on stocks. Ackman’s strategy is extremely risky. Show More Summary
Not even a $4 billion hole in his pocket can make the Pershing Square chief miss his second Sohn conference in a row.
Pershing Square Capital Management‘s Bill Ackman will be attending the Ira Sohn Investment Conference in New York this year, after skipping out last year. Photo by Bryan Bedder/Getty Images The Sohn confab is the Super Bowl of investor...Show More Summary
How much would you pay to avoid 12 hours of depositions?
Bill Ackman's hedge fund Pershing Square was once envied by Wall Street. It boasted 40% returns in 2014 -- 27% higher than the S&P 500 that year. The post Bill Ackman’s Three Worst Investments of All Time [LIST] was originally published at The Wall Street Examiner. Follow the money!
As Bill Ackman's Pershing Square Capital Management was exiting its position in Valeant Pharmaceuticals (VRX), activist firm ValueAct Capital Management was leaning in. It added some 3 million shares, increasing its stake to approximately...Show More Summary
A quick note on Valeant Pharmaceutical short sellers from Wall Street analytics firm, S3 Partners – something to give a little context to hedge fund billionaire Bill Ackman's exit from the company. " VRX short sellers were profitable...Show More Summary
One day after gloating at Bill Ackman over his $4 billion loss on Valeant, Dennis Gartman is back with his latest trade reco which may be worth paying attention to: he says that while he is getting "bullish of Japanese shares", he is offsetting this with an imminent short of markets across the "industrialized" world. Show More Summary